Youru Liu
Overview
Explore the profile of Youru Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
3
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ding J, Su Y, Liu Y, Xu Y, Yang D, Wang X, et al.
Cell Cycle
. 2024 Jan;
22(23-24):2622-2636.
PMID: 38166492
A protein called cleavage-stimulating factor subunit 2 (CSTF2, additionally called CSTF-64) binds RNA and is needed for the cleavage and polyadenylation of mRNA. CSTF2 is an important component subunit of...
2.
Dai S, Liu Y, Wang L, Han B, Jiang L
Zhongguo Fei Ai Za Zhi
. 2013 Jan;
16(1):38-42.
PMID: 23327872
Background: The prognostic factors and salvage therapy after the failure of epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) therapy have brought concerns. This study aims to analyze retrospectively the clinical...
3.
Wang X, Liu Y, Gao Z, Jiang Y, Han B, Jiang L
Zhongguo Fei Ai Za Zhi
. 2012 May;
15(5):294-8.
PMID: 22613336
Background And Objective: Pemetrexed and epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) were used in patients with EGFR mutation to determine their effects. This study analyzed the influence of...
4.
Niu Y, Jiang Y, Xu C, Wang X, Liu Y, Zhao H, et al.
Zhongguo Fei Ai Za Zhi
. 2012 Apr;
15(4):195-201.
PMID: 22510503
Background And Objective: Lung cancer is one of the most common cancers worldwide. Thus far, good tumor markers for diagnosing this disease have not been found. Therefore, the discovery of...
5.
Liu Y, Jiang Y, Gao Z, Wang X, Han B, Jiang L
Zhongguo Fei Ai Za Zhi
. 2011 Sep;
14(9):704-9.
PMID: 21924035
Background And Objective: At present, there is no standard salvage treatment strategies for lung cancer. The aim of this study is to compare the efficacies and safeties of pemetrexed alone...